High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P151
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ghamande, Sharad
Mauro, David
Price, Cheryl
Wheatley, Donna
Janik, John
Khleif, Samir N
Article History
First Online: 4 November 2015